S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|DCVax®-Direct Phase I/II Trial For All Inoperable Solid Tumors Is Expected To Produce Ongoing Results In 2013 (2013/3/5)|
|NW Bio Takes Next Steps In Moving Forward With Its Phase III Brain Cancer Trial In Europe (2013/2/15)|
|NW Bio Establishes Cross-Border Manufacturing And Distribution For DCVax® In Europe (2013/3/12)|
|NW Bio Receives U.S. Patent On Broad Processes For Producing More Potent Dendritic Cells (2013/3/18)|
|NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference (2013/3/19)|
|NW Bio's Phase III Trial With DCVax®-L For Brain Cancer "Adopted" As A National Priority Trial In UK (2013/4/16)|
|NW Bio Announces That Another Brain Cancer Patient From Phase I/II DCVax®-L Trials Has Surpassed Ten-Year Cancer-Free Survival (2013/4/18)|
|NW Bio Announces $10 Million Registered Direct Offering (2013/4/18)|
|Interviews Of NW Bio's CEO, On The Floor Of The New York Stock Exchange, Now Available Online (2013/5/3)|
|NW Bio Initiates Phase III DCVax®-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open (2013/5/16)|
Click above to view more mutual fund data and stats for nwbo - Northwest Biotherapeutics, Inc..